All Publications
2022
Demuro S., Sauvey C., Tripathi S.K., Di Martino R.M.C., Shi D., Ortega J.A., Russo D., Balboni B., Giabbai B., Storici P., Girotto S., Abagyan R., Cavalli A.
ARN25068, a versatile starting point towards triple GSK-3β/FYN/DYRK1A inhibitors to tackle tau-related neurological disorders
European Journal of Medicinal Chemistry, vol. 229
2022
Demuro S., Di Martino R.M.C., Ortega J.A., Sauvey C., Shi D., Tripathi S., Balboni B., Girotto S., Russo D., Penna I., Bandiera T., Ballatore C., Abagyan R., Cavalli A.
Development of multitarget-directed ligands (MTDLs) protein kinases inhibitors to tackle central nervous system (CNS)-related disorders
ACS Spring 2022 meeting
Abstract Report
Conference
2022
Mazzarella M.A., Berti F., Russo D., Penna I., Bottegoni G., Reggiani A., Bertozzi F., Bandiera T.
Identification of dual inhibitors to hit inflammation and neurodegeneration for multiple sclerosis therapy
European School of Medicinal Chemistry, 41st Advanced Course of Medicinal Chemistry and Seminar for PhD students
Poster
Conference
2022
Balboni B., Tripathi S.K., Veronesi M., Russo D., Penna I., Giabbai B., Bandiera T., Storici P., Girotto S., Cavalli A.
Identification of Novel GSK-3β Hits Using Competitive Biophysical Assays
International Journal of Molecular Sciences, vol. 23, (no. 7)
2021
Marotta G., Di Martino R.M.C., Russo D., Penna I., Rosini M., Ortega J.A., Minarini A.
DESIGN AND SYNTHESIS OF MULTITARGET-DIRECTED LIGANDS TO TACKLE NEUROINFLAMMATION
XX Giornata della Chimica dell’Emilia-Romagna (GdC-ER)
Poster
Conference
Colleagues of D3 PharmaChemistry
